Type 2 Diabetes Therapy
Soy isoflavones exert antidiabetic and hypolipidemic effects through PPAR
Published in Obesity and Diabetes Week, July 7th, 2003
"The hypocholesterolemic and anti-atherosclerotic mechanism by which soy may exert a beneficial effect remains unclear. Peroxisome-proliferator activated receptors PPAR) are promiscuous nuclear receptors that regulate the transcription of genes involved in lipid and glucose homeostasis and lipid metabolism within the cell. We hypothesize that the isoflavones improve lipid and glucose metabolism by acting as an antidiabetic PPAR agonist," scientists writing in the Journal of Nutrition report.
"Male and female obese Zucker rats...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Obesity Pathogenesis
Interleukin-1 receptor antagonist upregulated in obesity - Type 1 Diabetes Therapy
Nephroprotection provided by converting enzyme inhibitor in diabetic patients - Breast Cancer
Hormones in obese women linked to poor breast cancer survival - Erectile Dysfunction
Free radicals implicated in diabetes-related erectile dysfunction - Heart Disease Risk Factor
Albumin excretion and NO production tests identify patients at high CVD risk - Obesity Epidemiology
Researchers issue alarm for rise in obesity among older Australians - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
